On March 15th, Biologics 2024 successfully concluded in London, one of the largest global exhibitions for innovation, expertise, and partnership within the life sciences industry. The event gathered 650 pharma, biotech, and academic delegates and over 50 exhibitors, including Tsingke, GenScript, AstraZeneca、Sanofi、novartis, etc.
Biologics 2024 provided an important venue for discussing and exploring innovations in biologics. The delegates and industry exhibitors engaged in discussions on proteins, antibodies, peptides, oligonucleotides, and sustainability in biologics.
Tsingke, a globally renowned DNA/RNA synthesis company, stood out at the exhibition with cutting-edge innovative products, services, and the latest advancements. During in-depth discussions with numerous professionals and exhibitors, they were impressed by the leading positions of Tsingke in the fields of oligo synthesis and gene synthesis services, and most of them expressed a strong interest in collaboration.
Tsingke Continues to Innovate
At Biologics 2024, attendees had the opportunity to witness Tsingke’s groundbreaking innovations and formidable scientific prowess in the biologics sector.
As a national high-tech enterprise boasting over 300 independent intellectual property rights and hosting a national post-doctoral research station, through relentless pursuit of excellence, Tsingke is at the forefront of advancing biotechnology, paving the way for a promising future for humanity.
Showcase of Tsingke’s Advanced Products
In this conference on biologics research, Tsingke’s products stood out and became the focus among audiences. Leading biotechnology includes:
1. Oligo Synthesis
In the Biologics 2024 conference, oligo synthesis services have taken center stage, particularly with Tsingke’s oligo synthesis service attracting considerable attention and interest among participants.
Renowned for its reliability, Tsingke provides synthesis capabilities spanning from microgram to kilogram quantities, guaranteeing precise molecular weights and offering a variety of modification options. also, its expertise lies in synthesizing RNA oligos up to 120 nucleotides in length and DNA oligos exceeding 250 nucleotides.
Key characteristics of this service include:
● Our facilities boast a 100,000-level clean room alongside an ISO 13485 certification, endorsed by SGS
● Trust by over 500 IVD companies
● Various QC Methods
2. Gene Synthesis
Tsingke’s gene synthesis service, powered by the intelligent Tsynth™ synthesis technology, can construct genes with 100% sequence accuracy after undergoing Tsingke’s NGS and Sanger sequencing validation.
It also stood out at Biologics 2024 as the preferred choice of many attendees for its customization, cost-effectiveness, and fast 5-day delivery.
Other features of this gene synthesis service include:
● Achieved construction of 200kb plasmid
● Free 160+ commercial vectors
● No mutation and contamination
● Free codon optimization
● Unique Intelligent Splitting Algorithm
3. Protein Expression
Audiences at Biologics 2024 were attracted by Tsingke’s rapid, high-success, high-purity, and cost-effective protein expression service, which maximizes research outcomes. Tsingke provides a one-stop service from sequence design to expression purification.
Its top advantage is versatile expression systems offer researchers a range of options for specific needs, including bacterial, yeast, insect, mammalian, and bacillus subtilis.
4. Antibody Service
At Biologics 2024, many experts also paid attention to the development of therapeutic antibody technology.
Recombinant antibody expression technology has led to the emergence of many new antibody therapies, making significant contributions to the treatment and diagnosis of diseases. Tsingke provides a one-stop service platform from gene to antibody expression to meet extensive needs for specific applications.
Its standout attribute lies in leveraging a high-throughput transient transfection platform for antibody expression, enabling the swift production of recombinant antibodies in as little as one week.
Celebrating Tsingke’s Achievements
Tsingke has come a long way since commencing operations. In addition to developing core technologies, the brand has also expanded its global customer base to over 200,000 satisfied users worldwide. The 12,000 square meter R&D base, 100,000 grade clean production workshop and ISO13485 certification emphasize their innovative capability and product quality.
As a high-tech enterprise, Tsingke continuously develops and improves its innovation and research and development system while serving users. Thanks to advanced gene synthesis and antibody services, many vaccines and treatment methods for rare diseases have made breakthroughs.
Tsingke’s prominence at Biologics 2024 reflected the brand’s standing as a leader in fields like oligo and gene synthesis. Going forward, the company will continue optimizing production capabilities to set new industry benchmarks. Looking forward to their future performance!
For more information about oligo synthesis service, contact Tsingke’s professionals now!